KARL STORZ PHOTODYNAMIC DIAGNOSTIC D-LIGHT C (PDD) SYSTEM
Karl Storz Endoscopy-America, Inc. · Decision date May 28, 2010
What did the FDA approve?
The May 28, 2010 approval covers the KARL STORZ Photodynamic Diagnostic D-Light C (PDD) System, a diagnostic endoscopic light source system. The stated scope is use in combination with the optical imaging drug Cysview (hexaminolevulinate hydrochloride) for intravesical solution for photodynamic blue light cystoscopy, as an adjunct to white light cystoscopy.
The stated purpose is detection of non-muscle invasive papillary cancer of the bladder in patients suspected or known to have the lesion on the basis of a prior cystoscopy. The source statement reports an intended use; it does not independently establish safety or clinical effectiveness. No supplement type or reason is supplied.
FDA approval order statement
APPROVAL FOR THE KARL STORZPHOTODYNAMIC DIAGNOSTIC D-LIGHT C (PDD) SYSTEM. THE KARL STORZ PHOTODYNAMIC DIAGNOSTIC D-LIGHTC (PDD) SYSTEM IN COMBINATION WITH THE OPTICAL IMAGING DRUG CYSVIEW(HEXAMINOLEVULINATE HYDROCHLORIDE) FOR INTRAVESICAL SOLUTION IS INDICATED FOR PHOTODYNAMIC BLUELIGHT CYSTOSCOPY, AS AN ADJUNCT TO WHITE LIGHT CYSTOSCOPY FOR THE DETECTION OF NON-MUSCLE INVASIVEPAPILLARY CANCER OF THE BLADDER IN PATIENTS SUSPECTED OR KNOWN TO HAVE THE LESION ON THE BASIS OF A PRIOR CYSTOSCOPY.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- May 28, 2010
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P050027
- Regulatory pathway
- Premarket approval application
- Applicant
- Karl Storz Endoscopy-America, Inc.
- Product code
- OAY
- Decision code
- APPR
- Decision date
- May 28, 2010
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light source system, diagnostic endoscopic.
- Applicant
- Karl Storz Endoscopy-America, Inc.
- Product code
- OAY
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P050027 received
Application receipt date recorded by FDA.
P050027 · FDA decision
APPR
P050027/S038 · Related supplement
Photodynamic Diagnostic D-Light C System
Timeline entries are records held by MedtechLedger for P050027. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P050027
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Photodynamic Diagnostic D-Light C SystemP050027/S038 | Karl Storz Endoscopy-America, Inc. | PMA supplement | Oct 14, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Karl Storz Endoscopy-America, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 2151 E. Grand Ave., El Segundo, CA, 90245
Sources and methodology
- Original FDA record: P050027
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records